MedTrace Logo

Loading Regimen，Serum Trough Concentrations，Efficacy and Safety in Pneumonia Patients With Gram-positive Infections

NCT03229135 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2017-07-25

No results posted yet for this study

Summary

This was a retrospective study that all teicoplanin-treated adult patients with Gram-positive infections admitted to Zhengzhou Central Hospital affiliated to Zhengzhou University from February 2015 to August 2016.

Conditions

  • Pneumonia Gram-Positive Bacterial

Interventions

DEVICE

other antibacterial agents，breathing machine

If treatment failure for patients in group A，group B，group C and group D，change dose of teicoplanin or other antibacterial agents. Mechanical ventilation was adopte.Treatment failure was defined as no improvement or worse of clinical symptoms, laboratory data, requiring change of teicoplanin therapy.

Sponsors & Collaborators

  • People's Hospital of Zhengzhou University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-01
Primary Completion
2016-08-20
Completion
2016-10-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03229135 on ClinicalTrials.gov